Cardiovascular, Renal and Metabolism

Attacking a cluster

Metabolic diseases affect close to one billion people worldwide. Only four years old, the team is combining unparalleled clinical expertise with basic research and a renowned protein engineering technology platform. Our drug discovery teams are poised to deliver innovative therapies for cardiometabolic diseases and are already moving to the clinic.


Our Pipeline

Cardiovascular, Renal and Metabolism

Phase 1

Phase 1

  • MEDI7219 type-2 diabetes

Phase 2

Phase 2

  • MEDI0382 type-2 diabetes/obesity
  • MEDI5884 cardiovascular
  • MEDI6012 cardiovascular

Phase 3

Phase 3

LCM Projects

LCM Projects

Cardiovascular, Renal and Metabolism News

Cardiovascular, Renal and Metabolism Publications


Join us at MedImmune

Our Great Place to Work strategic initiative offers a dynamic environment that fosters collaboration and innovation. We attract top minds, and we do what it takes to nurture and build talent.